Do analysts prefer ACU or QDEL?

QuidelOrtho has a consensus price target of $13.63, suggesting a potential upside of 29.27%. Given QuidelOrtho's higher possible upside, analysts plainly believe QuidelOrtho is more favorable than Acme United. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Acme United 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 QuidelOrtho 3 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to ACU or QDEL?

In the previous week, Acme United and Acme United both had 5 articles in the media. QuidelOrtho's average media sentiment score of 0.79 beat Acme United's score of 0.77 indicating that QuidelOrtho is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acme United 0 Very Positive mention(s) 5 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QuidelOrtho 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ACU or CERS?

Cerus has a consensus price target of $5.25, indicating a potential upside of 120.59%. Given Cerus' higher possible upside, analysts clearly believe Cerus is more favorable than Acme United. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Acme United 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Cerus 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has stronger valuation and earnings, ACU or CERS?

Acme United has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Acme United $211.60M 1.14 $17.79M $2.38 26.65 Cerus $206.13M 2.33 -$15.63M -$0.03 N/A

Is ACU or CERS more profitable?

Acme United has a net margin of 10.25% compared to Cerus' net margin of -3.06%. Acme United's return on equity of 9.70% beat Cerus' return on equity. Company Net Margins Return on Equity Return on Assets Acme United 10.25% 9.70% 6.10% Cerus -3.06% -10.19% -3.14%

Does the media favor ACU or CERS?

In the previous week, Acme United had 2 more articles in the media than Cerus. MarketBeat recorded 5 mentions for Acme United and 3 mentions for Cerus. Cerus' average media sentiment score of 0.83 beat Acme United's score of 0.77 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acme United 0 Very Positive mention(s) 5 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ACU or SMTI?

Sanara MedTech has a consensus target price of $35.00, suggesting a potential downside of 0.40%. Given Sanara MedTech's higher probable upside, analysts clearly believe Sanara MedTech is more favorable than Acme United. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Acme United 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Sanara MedTech 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80

Which has stronger valuation and earnings, ACU or SMTI?

Acme United has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Acme United $211.60M 1.14 $17.79M $2.38 26.65 Sanara MedTech $103.12M 3.13 -$37.56M -$3.59 N/A

Does the media refer more to ACU or SMTI?

In the previous week, Acme United had 2 more articles in the media than Sanara MedTech. MarketBeat recorded 5 mentions for Acme United and 3 mentions for Sanara MedTech. Acme United's average media sentiment score of 0.77 beat Sanara MedTech's score of 0.71 indicating that Acme United is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acme United 0 Very Positive mention(s) 5 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sanara MedTech 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate EMBC or ACU?

Embecta presently has a consensus target price of $11.00, suggesting a potential upside of 94.17%. Given Embecta's higher possible upside, equities research analysts plainly believe Embecta is more favorable than Acme United. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Embecta 2 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.60 Acme United 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00

Which has stronger valuation and earnings, EMBC or ACU?

Embecta has higher revenue and earnings than Acme United. Embecta is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Embecta $1.08B 0.30 $95.40M $1.48 3.83 Acme United $211.60M 1.14 $17.79M $2.38 26.65

Is EMBC or ACU more profitable?

Acme United has a net margin of 10.25% compared to Embecta's net margin of 8.59%. Acme United's return on equity of 9.70% beat Embecta's return on equity. Company Net Margins Return on Equity Return on Assets Embecta 8.59% -19.25% 10.82% Acme United 10.25% 9.70% 6.10%

Does the media prefer EMBC or ACU?

In the previous week, Acme United had 3 more articles in the media than Embecta. MarketBeat recorded 5 mentions for Acme United and 2 mentions for Embecta. Embecta's average media sentiment score of 0.89 beat Acme United's score of 0.77 indicating that Embecta is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Embecta 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Acme United 0 Very Positive mention(s) 5 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ACU or OSUR?

OraSure Technologies has a consensus target price of $3.00, suggesting a potential downside of 23.47%. Given OraSure Technologies' higher possible upside, analysts clearly believe OraSure Technologies is more favorable than Acme United. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Acme United 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 OraSure Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media prefer ACU or OSUR?

In the previous week, Acme United had 2 more articles in the media than OraSure Technologies. MarketBeat recorded 5 mentions for Acme United and 3 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.98 beat Acme United's score of 0.77 indicating that OraSure Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acme United 0 Very Positive mention(s) 5 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OraSure Technologies 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Acme United (ACU) Competitors

$63.42 -0.30 (-0.47%)

Closing price 04:00 PM Eastern

Extended Trading

$63.34 -0.09 (-0.13%)

As of 07:30 PM Eastern

Compare

ACU vs. QDEL, CERS, SMTI, EMBC, and OSUR

Should you buy Acme United stock or one of its competitors? Acme United's main competitors and comparable companies include QuidelOrtho (QDEL), Cerus (CERS), Sanara MedTech (SMTI), Embecta (EMBC), and OraSure Technologies (OSUR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Acme United compare to QuidelOrtho?

Acme United (NYSE:ACU) and QuidelOrtho (NASDAQ:QDEL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

62.1% of Acme United shares are held by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are held by institutional investors. 29.5% of Acme United shares are held by insiders. Comparatively, 1.1% of QuidelOrtho shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Acme United has a net margin of 10.25% compared to QuidelOrtho's net margin of -39.20%. Acme United's return on equity of 9.70% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acme United	10.25%	9.70%	6.10%
QuidelOrtho	-39.20%	4.88%	1.63%

Acme United has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

QuidelOrtho has a consensus price target of $13.63, suggesting a potential upside of 29.27%. Given QuidelOrtho's higher possible upside, analysts plainly believe QuidelOrtho is more favorable than Acme United.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acme United	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
QuidelOrtho	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Acme United has higher earnings, but lower revenue than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acme United	$211.60M	1.14	$17.79M	$2.38	26.65
QuidelOrtho	$2.73B	0.26	-$1.13B	-$15.41	N/A

In the previous week, Acme United and Acme United both had 5 articles in the media. QuidelOrtho's average media sentiment score of 0.79 beat Acme United's score of 0.77 indicating that QuidelOrtho is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acme United	0 Very Positive mention(s)	5 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QuidelOrtho	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Acme United beats QuidelOrtho on 10 of the 15 factors compared between the two stocks.

How does Acme United compare to Cerus?

Acme United (NYSE:ACU) and Cerus (NASDAQ:CERS) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

Acme United has a net margin of 10.25% compared to Cerus' net margin of -3.06%. Acme United's return on equity of 9.70% beat Cerus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acme United	10.25%	9.70%	6.10%
Cerus	-3.06%	-10.19%	-3.14%

Acme United has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market. Comparatively, Cerus has a beta of 1.8, meaning that its share price is 80% more volatile than the broader market.

62.1% of Acme United shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 29.5% of Acme United shares are held by insiders. Comparatively, 5.3% of Cerus shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Acme United has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acme United	$211.60M	1.14	$17.79M	$2.38	26.65
Cerus	$206.13M	2.33	-$15.63M	-$0.03	N/A

Cerus has a consensus price target of $5.25, indicating a potential upside of 120.59%. Given Cerus' higher possible upside, analysts clearly believe Cerus is more favorable than Acme United.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acme United	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Cerus	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Acme United had 2 more articles in the media than Cerus. MarketBeat recorded 5 mentions for Acme United and 3 mentions for Cerus. Cerus' average media sentiment score of 0.83 beat Acme United's score of 0.77 indicating that Cerus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acme United	0 Very Positive mention(s)	5 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cerus	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Acme United beats Cerus on 11 of the 17 factors compared between the two stocks.

How does Acme United compare to Sanara MedTech?

Acme United (NYSE:ACU) and Sanara MedTech (NASDAQ:SMTI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Acme United has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acme United	$211.60M	1.14	$17.79M	$2.38	26.65
Sanara MedTech	$103.12M	3.13	-$37.56M	-$3.59	N/A

In the previous week, Acme United had 2 more articles in the media than Sanara MedTech. MarketBeat recorded 5 mentions for Acme United and 3 mentions for Sanara MedTech. Acme United's average media sentiment score of 0.77 beat Sanara MedTech's score of 0.71 indicating that Acme United is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acme United	0 Very Positive mention(s)	5 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sanara MedTech	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sanara MedTech has a consensus target price of $35.00, suggesting a potential downside of 0.40%. Given Sanara MedTech's higher probable upside, analysts clearly believe Sanara MedTech is more favorable than Acme United.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acme United	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Sanara MedTech	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

Acme United has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market. Comparatively, Sanara MedTech has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market.

Acme United has a net margin of 10.25% compared to Sanara MedTech's net margin of -29.15%. Sanara MedTech's return on equity of 29.72% beat Acme United's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acme United	10.25%	9.70%	6.10%
Sanara MedTech	-29.15%	29.72%	2.84%

62.1% of Acme United shares are held by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are held by institutional investors. 29.5% of Acme United shares are held by company insiders. Comparatively, 42.0% of Sanara MedTech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Acme United beats Sanara MedTech on 11 of the 16 factors compared between the two stocks.

How does Acme United compare to Embecta?

Embecta (NASDAQ:EMBC) and Acme United (NYSE:ACU) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

Embecta presently has a consensus target price of $11.00, suggesting a potential upside of 94.17%. Given Embecta's higher possible upside, equities research analysts plainly believe Embecta is more favorable than Acme United.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60
Acme United	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00

Embecta has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Acme United has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market.

In the previous week, Acme United had 3 more articles in the media than Embecta. MarketBeat recorded 5 mentions for Acme United and 2 mentions for Embecta. Embecta's average media sentiment score of 0.89 beat Acme United's score of 0.77 indicating that Embecta is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Embecta	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Acme United	0 Very Positive mention(s)	5 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Embecta pays an annual dividend of $0.04 per share and has a dividend yield of 0.7%. Acme United pays an annual dividend of $0.64 per share and has a dividend yield of 1.0%. Embecta pays out 2.7% of its earnings in the form of a dividend. Acme United pays out 26.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Acme United has increased its dividend for 20 consecutive years. Acme United is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

93.8% of Embecta shares are held by institutional investors. Comparatively, 62.1% of Acme United shares are held by institutional investors. 1.3% of Embecta shares are held by company insiders. Comparatively, 29.5% of Acme United shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Acme United has a net margin of 10.25% compared to Embecta's net margin of 8.59%. Acme United's return on equity of 9.70% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Embecta	8.59%	-19.25%	10.82%
Acme United	10.25%	9.70%	6.10%

Embecta has higher revenue and earnings than Acme United. Embecta is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.08B	0.30	$95.40M	$1.48	3.83
Acme United	$211.60M	1.14	$17.79M	$2.38	26.65

Summary

Acme United beats Embecta on 11 of the 19 factors compared between the two stocks.

How does Acme United compare to OraSure Technologies?

Acme United (NYSE:ACU) and OraSure Technologies (NASDAQ:OSUR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Acme United has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market. Comparatively, OraSure Technologies has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market.

OraSure Technologies has a consensus target price of $3.00, suggesting a potential downside of 23.47%. Given OraSure Technologies' higher possible upside, analysts clearly believe OraSure Technologies is more favorable than Acme United.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acme United	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Acme United has a net margin of 10.25% compared to OraSure Technologies' net margin of -43.70%. Acme United's return on equity of 9.70% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acme United	10.25%	9.70%	6.10%
OraSure Technologies	-43.70%	-19.09%	-16.26%

Acme United has higher revenue and earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acme United	$211.60M	1.14	$17.79M	$2.38	26.65
OraSure Technologies	$115.02M	2.35	-$68.73M	-$0.69	N/A

In the previous week, Acme United had 2 more articles in the media than OraSure Technologies. MarketBeat recorded 5 mentions for Acme United and 3 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.98 beat Acme United's score of 0.77 indicating that OraSure Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acme United	0 Very Positive mention(s)	5 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

62.1% of Acme United shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 29.5% of Acme United shares are held by company insiders. Comparatively, 4.7% of OraSure Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Acme United beats OraSure Technologies on 11 of the 16 factors compared between the two stocks.

Get Acme United News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACU vs. The Competition

Export

Metric	Acme United	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$241.63M	$5.51B	$7.30B	$22.84B
Dividend Yield	1.02%	1.79%	2.52%	3.72%
P/E Ratio	12.97	20.89	214.19	23.85
Price / Sales	1.14	69.06	613.72	21.42
Price / Cash	10.02	32.86	79.75	40.95
Price / Book	2.32	5.68	10.34	4.60
Net Income	$17.79M	$149.51M	$3.50B	$1.08B
7 Day Performance	1.05%	-2.33%	-1.70%	-1.99%
1 Month Performance	0.57%	-5.95%	-4.61%	-6.24%
1 Year Performance	54.01%	4.94%	12.41%	5.07%

Acme United Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACU Acme United	0.9946 of 5 stars	$63.42 -0.5%	N/A	+57.0%	$241.63M	$211.60M	12.97	649	News Coverage
QDEL QuidelOrtho	2.7777 of 5 stars	$10.94 +0.7%	$13.63 +24.5%	-63.3%	$744.73M	$2.73B	N/A	6,500
CERS Cerus	1.6865 of 5 stars	$2.67 +4.3%	$5.25 +96.6%	+62.5%	$515.90M	$206.13M	N/A	345	High Trading Volume
SMTI Sanara MedTech	0.731 of 5 stars	$35.28 +0.3%	$35.00 -0.8%	+10.2%	$323.14M	$103.12M	N/A	108	News Coverage
EMBC Embecta	4.0824 of 5 stars	$5.59 +5.5%	$11.00 +96.8%	-58.9%	$300.30M	$1.08B	3.78	1,850

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ACU) was last updated on 9/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Acme United (ACU) Competitors

ACU vs. QDEL, CERS, SMTI, EMBC, and OSUR

How does Acme United compare to QuidelOrtho?

Summary

How does Acme United compare to Cerus?

Summary

How does Acme United compare to Sanara MedTech?

Summary

How does Acme United compare to Embecta?

Summary

How does Acme United compare to OraSure Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACU vs. The Competition

Acme United Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Acme United (ACU) Competitors

ACU vs. QDEL, CERS, SMTI, EMBC, and OSUR

How does Acme United compare to QuidelOrtho?

Do institutionals & insiders hold more shares of ACU or QDEL?

Is ACU or QDEL more profitable?

Which has more risk and volatility, ACU or QDEL?

Do analysts prefer ACU or QDEL?

Which has higher valuation & earnings, ACU or QDEL?

Does the media refer more to ACU or QDEL?

Summary

How does Acme United compare to Cerus?

Is ACU or CERS more profitable?

Which has more risk and volatility, ACU or CERS?

Do institutionals and insiders have more ownership in ACU or CERS?

Which has stronger valuation and earnings, ACU or CERS?

Do analysts recommend ACU or CERS?

Does the media favor ACU or CERS?

Summary

How does Acme United compare to Sanara MedTech?

Which has stronger valuation and earnings, ACU or SMTI?

Does the media refer more to ACU or SMTI?

Do analysts recommend ACU or SMTI?

Which has more risk & volatility, ACU or SMTI?

Is ACU or SMTI more profitable?

Do institutionals & insiders believe in ACU or SMTI?

Summary

How does Acme United compare to Embecta?

Do analysts rate EMBC or ACU?

Which has more risk and volatility, EMBC or ACU?

Does the media prefer EMBC or ACU?

Is EMBC or ACU a better dividend stock?

Do institutionals & insiders hold more shares of EMBC or ACU?

Is EMBC or ACU more profitable?

Which has stronger valuation and earnings, EMBC or ACU?

Summary

How does Acme United compare to OraSure Technologies?

Which has more volatility & risk, ACU or OSUR?

Do analysts prefer ACU or OSUR?

Is ACU or OSUR more profitable?

Which has stronger valuation & earnings, ACU or OSUR?

Does the media prefer ACU or OSUR?

Do insiders & institutionals hold more shares of ACU or OSUR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACU vs. The Competition

Acme United Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools